Hugo is about to joust da Vinci. It’s not a battle between Renaissance geniuses. Instead, a commercial fight is brewing between massive medtech companies to control the future of the ...

Medtronic’s Hugo robotic surgery system earns FDA clearance, ending Intuitive’s long-held dominance and reshaping the future of soft-tissue robotics.

Medtronic said Wednesday it obtained U.S. clearance for its Hugo system in urologic procedures, positioning the medtech giant to challenge Intuitive Surgical in the world’s largest robotic surgery ...

In early December 2025, Medtronic’s board approved a US$0.71 per-share cash dividend for the third quarter of fiscal 2026, payable on January 16, 2026, and the company secured FDA clearance for its ...

FDA has greenlit Medtronic’s Hugo Robotic-Assisted Surgery system for urological surgical procedures, in perhaps one of the biggest regulatory clearances of the year. The move comes a little more than ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. The FDA granted an initial green light to the soft-tissue system for urologic ...

Medtronic and CMR Surgical got the FDA’s green light this month, while SS Innovations applied for clearance. Catch up on the ...

The Hugo RAS system’s clearance brings a versatile robotic-assisted platform to U.S. surgeons and health systems seeking to expand soft-tissue robotic surgery programs and access to minimally invasive ...

Medtronic plc (NYSE:MDT) Wednesday announced the commencement of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to assess the safety and effectiveness of its Hugo ...

Intuitive Surgical's recent results highlight the growth potential in robotic surgery. Medtronic, with a more diversified business, is getting into the surgical-robot game. Its stock has an ...

CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.